Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Cinnamamide: a lead compound for the design of structurally unique MMP inhibitors

March 8, 2000

Heparinase-inhibitory fungal metabolites discovered by Korean/Japanese research team

March 7, 2000

Ilex Oncology acquires U.S. operations of British Biotech

March 7, 2000

Daiichi claims pyrazole derivatives as antitumor agents

March 7, 2000

New epipodophyllotoxin anticancer agent reported; studies on mechanism of action described

March 7, 2000

Structure elucidation, biological activity of a novel antimitotic agent: FR-182877

March 7, 2000

Squalamine enters combination trials with cisplatin for advanced cancer

March 7, 2000

Immunomedics updates progress with genetically engineered cancer immunotherapy

March 6, 2000

First report of sequence-specific DNA dialkylation with diamide-CPI conjugate

March 6, 2000

Triapine anticancer therapy completes phase I trial

March 3, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026